Duality Advisers, LP Chemo Centryx, Inc. Transaction History

Duality Advisers, LP

  • $0
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021
SELL
$9.59 - $50.88 $201,802 - $1.07 Million
-21,043 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$49.53 - $68.4 $130,016 - $179,550
-2,625 Reduced 11.09%
21,043 $1.08 Million
Q4 2020

Feb 09, 2021
BUY
$47.25 - $65.16 $1.12 Million - $1.54 Million
23,668 New
23,668 $1.47 Million

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email